🇺🇸 FDA
Company

InMed

InMed Pharmaceuticals

INM pharma USA

Quick answer

InMed is a pharma company (INM) headquartered in VANCOUVER, A1, USA with 1 tracked pipeline programs.

Pipeline (1)

project

INM-755 (cannabinol) cream

Epidermolysis Bullosa Simplex

Phase 2 · small_molecule · completed

1 trials

Patents (8)

patent

US 12357604

Topical formulations of cannabinoids and use thereof in the treatment of pain

Expires Mon Jul 10 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12083229

Ocular drug delivery formulation

Expires Mon Sep 05 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12042479

Use of topical formulations of cannabinoids in the treatment of epidermolysis bu

Expires Mon Jul 18 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11471534

Chitosan-pluronic complex and nano-carrier comprising same

Expires Mon Oct 13 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11472840

Acetylcholine receptor-binding peptide

Expires Mon Oct 13 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 8361485

Conditioned cell culture medium compositions and methods of use

Expires Mon Jan 24 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 8268336

Compositions containing aromatic aldehydes and their use in treatments

Expires Mon Sep 13 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 8246971

Compositions containing aromatic aldehydes and their use in treatment

Expires Mon Aug 16 2032 00:00:00 GMT+0000 (Coordinated Universal Time)